Drugs / Propacetamol
Propacetamol
also known as
denogan · Pro-Dafalgan · Propacetamol (Denogan, Yungjin, Seoul, Korea) · Propacetamol hydrochloride
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase not applicable3 trials | ||||||
| — | NCT02577068 | Nov 2015 → Aug 2016 | thyroid gland disorder | Yonsei University | Completed | No outcome recorded |
| — | NCT02515188 | Aug 2015 → Jun 2016 | cardiac rhythm disease | Yonsei University | Completed | No outcome recorded |
| — | NCT02116257 | Nov 2013 → Mar 2015 | — | Yonsei University | Completed | No outcome recorded |
| Comparator or background therapy5 trials | ||||||
| — | NCT03878082 Comparator | Aug 2019 → Dec 2022 | uterine disorder | Mackay Memorial Hospital | Completed | No outcome recorded |
| — | NCT03352362 Comparator | Dec 2017 → Mar 2019 | — | Yonsei University | Completed | Met primary |
| — | NCT02355678 Background | Jan → Aug 2015 | — | Makassed General Hospital | Completed | Missed primary |
| — | NCT02012244 Background | Jan → Dec 2014 | colorectal cancer | Severance Hospital | Completed | No outcome recorded |
| — | NCT01833728 Comparator | Apr 2013 → Jan 2014 | kidney neoplasm | Yonsei University | Completed | No outcome recorded |
Evidence & citations 7 cited values
Every value below carries the sentence it was read from. 9 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | propacetamol | “continuous wound inflitration with ropivacaine + tramadol patient-controlled analgesia + additional ketorolac or propacetamol for postoperative 48 hour” NCT02012244 ↗ |
| Known as | denogan | “propacetamol (denogan 30 mg / kg)” NCT03352362 ↗ |
| Known as | Pro-Dafalgan | “15mg/kg intravenous propacetamol hydrochloride (Pro-Dafalgan Laboratoires, UPSA, Agen, France) will be provided.” NCT02355678 ↗ |
| Known as | Propacetamol (Denogan, Yungjin, Seoul, Korea) | “Propacetamol (Denogan®, Yungjin, Seoul, Korea)” NCT02515188 ↗ |
| Known as | Propacetamol hydrochloride | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02355678 ↗ |
| Modality | Small molecule | — CHEMBL1851805 ↗ |
| Route | Intravenous | “15mg/kg intravenous propacetamol hydrochloride” NCT02355678 ↗ |